With the advent of HAART, dramatic progress has been made in the treatment of children with HIV infection. Rates of perinatal transmission have fallen significantly because of increased prenatal and newborn testing. New research has demonstrated the long-term positive effects of HAART on immune status, growth, and development. The metabolic effects of HAART are being evaluated. Improving medication adherence and managing psychosocial stressors continue to be challenges to treatment, particularly in adolescents.
|Original language||English (US)|
|Number of pages||9|
|Journal||Infections in Medicine|
|State||Published - Jan 1 2008|
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases